162 related articles for article (PubMed ID: 28987723)
1. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.
Goicoechea M; Sanchez-Niño MD; Ortiz A; García de Vinuesa S; Quiroga B; Bernis C; Morales E; Fernández-Juarez G; de Sequera P; Verdalles U; Verde E; Luño J
Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():8-13. PubMed ID: 28987723
[TBL] [Abstract][Full Text] [Related]
2. Impaired resolution of inflammation in human chronic heart failure.
Reina-Couto M; Carvalho J; Valente MJ; Vale L; Afonso J; Carvalho F; Bettencourt P; Sousa T; Albino-Teixeira A
Eur J Clin Invest; 2014 Jun; 44(6):527-38. PubMed ID: 24673112
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin increases 15-epi-lipoxins A
Gonzalez-Brown VM; Ma'ayeh M; Kniss DA; Cackovic M; Landon MB; Rood KM
Pregnancy Hypertens; 2021 Dec; 26():75-78. PubMed ID: 34563982
[TBL] [Abstract][Full Text] [Related]
4. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
5. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
6. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics.
Sanak M; Levy BD; Clish CB; Chiang N; Gronert K; Mastalerz L; Serhan CN; Szczeklik A
Eur Respir J; 2000 Jul; 16(1):44-9. PubMed ID: 10933083
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipoxin A
Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
[TBL] [Abstract][Full Text] [Related]
8. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
Serhan CN; Chiang N
ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
[TBL] [Abstract][Full Text] [Related]
9. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
[TBL] [Abstract][Full Text] [Related]
10. Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial.
Chiang N; Hurwitz S; Ridker PM; Serhan CN
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):e14-7. PubMed ID: 16293793
[TBL] [Abstract][Full Text] [Related]
11. The effect of aspirin on gingival crevicular fluid levels of inflammatory and anti-inflammatory mediators in patients with gingivitis.
Kim DM; Koszeghy KL; Badovinac RL; Kawai T; Hosokawa I; Howell TH; Karimbux NY
J Periodontol; 2007 Aug; 78(8):1620-6. PubMed ID: 17668982
[TBL] [Abstract][Full Text] [Related]
12. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation.
Gewirtz AT; Fokin VV; Petasis NA; Serhan CN; Madara JL
Am J Physiol; 1999 Apr; 276(4):C988-94. PubMed ID: 10199831
[TBL] [Abstract][Full Text] [Related]
13. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Nishi SP; Martinez JD; Huang MH; Uretsky BF; Perez-Polo JR
Circulation; 2006 Aug; 114(9):929-35. PubMed ID: 16908763
[TBL] [Abstract][Full Text] [Related]
15. Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population.
Yu D; Xu Z; Yin X; Zheng F; Lin X; Pan Q; Li H
PLoS One; 2015; 10(11):e0142848. PubMed ID: 26565966
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases.
Pouliot M; Serhan CN
J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking.
Bandeira-Melo C; Bozza PT; Diaz BL; Cordeiro RS; Jose PJ; Martins MA; Serhan CN
J Immunol; 2000 Mar; 164(5):2267-71. PubMed ID: 10679058
[TBL] [Abstract][Full Text] [Related]
18. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
Marginean A; Sharma-Walia N
Transl Res; 2015 Aug; 166(2):111-33. PubMed ID: 25814167
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
[TBL] [Abstract][Full Text] [Related]
20. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
